TY  - JOUR
AU  - Bostyn, S.
PY  - 0517
DA  - 2021-05-17
T1  - Why a COVID IP Waiver Is not a Good Strategy
UR  - https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3843327
K1  - access to drugs
K1  - covid-19
K1  - data exclusivity
K1  - frontpage
K1  - intellectual property rights
K1  - Intellectuele eigendom
K1  - market exclusivity
K1  - pandemic
K1  - Patent law
K1  - patents
K1  - population health
K1  - SARS-CoV-2
K1  - trade secrets
K1  - TRIPS
K1  - vaccines
K1  - waiver
K1  - WTO
ER  -